Roflumilast 0.3%. Roflumilast and its active metabolite (roflumilast N-oxide) are inhibitors of phosphodiesterase 4 (PDE4). Roflumilast and roflumilast N-oxide inhibition of PDE4 (a major cyclic-3 ...
The pharmacological effects of beta 2-adrenoceptor agonist drugs are at least in part attributable to stimulation of intracellular ... adenosine triphosphate (ATP) to cyclic-3, 5-adenosine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback